Thomas A. Davis
Net Worth
Last updated:
What is Thomas A. Davis net worth?
The estimated net worth of Dr. Thomas A. Davis is at least $1,899,553 as of 4 Apr 2022. He owns shares worth $41 as insider, has earned $4,352 from insider trading and has received compensation worth at least $1,895,160 in Genocea Biosciences, Inc..
What is the salary of Thomas A. Davis?
Dr. Thomas A. Davis salary is $631,720 per year as Chief Medical Officer in Genocea Biosciences, Inc..
How old is Thomas A. Davis?
Dr. Thomas A. Davis is 61 years old, born in 1964.
What stocks does Thomas A. Davis currently own?
As insider, Dr. Thomas A. Davis owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Genocea Biosciences, Inc. (GNCA) | Chief Medical Officer | 68,330 | $0 | $41 |
What does Genocea Biosciences, Inc. do?
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.
Thomas A. Davis insider trading
Genocea Biosciences, Inc.
Dr. Thomas A. Davis has made 2 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 1,091 units of GNCA stock worth $1,364 on 4 Apr 2022.
The largest trade he's ever made was exercising 2,717 units of GNCA stock on 16 Mar 2022. As of 4 Apr 2022 he still owns at least 68,330 units of GNCA stock.
Genocea Biosciences key executives
Genocea Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Girish N. Aakalu Ph.D. (50) Chief Bus. Officer
- Dr. Thomas A. Davis (61) Chief Medical Officer
- Mr. William D. Clark M.B.A. (56) Pres, Chief Executive Officer & Director